546-88-3 | N-hydroxyacetamide

Packsize	Purity	Availability	Price	Discounted Price
100mg	98%	in stock	$6.00	$4.00
5g	98%	in stock	$8.00	$5.00
10g	98%	in stock	$10.00	$7.00
25g	98%	in stock	$20.00	$14.00
100g	98%	in stock	$46.00	$32.00

Description

• Catalog Number: AB50988
• Chemical Name: N-hydroxyacetamide
• CAS Number: 546-88-3
• Molecular Formula: C2H5NO2
• Molecular Weight: 75.0666
• MDL Number: MFCD00009994
• SMILES: CC(=O)NO

Computed Properties

• Complexity: 42.9
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 5
• Hydrogen Bond Acceptor Count: 2
• Hydrogen Bond Donor Count: 2
• XLogP3: -1.6

Upstream Synthesis Route

N-hydroxyacetamide is a versatile compound widely used in various chemical synthesis reactions as a key building block. Its hydroxyl group enables it to participate in numerous reactions, making it a valuable tool for synthetic chemists. One of the primary applications of N-hydroxyacetamide is as a precursor in the synthesis of hydroxamic acids, which are essential in the formation of metal chelating agents and histone deacetylase inhibitors. Additionally, N-hydroxyacetamide can be utilized in the preparation of various pharmaceutical compounds, polymers, and agricultural chemicals. Its unique chemical properties make it a crucial component in the development of diverse organic molecules with potential applications across industries.

Literature

• Growth-inhibiting, bactericidal, and urease inhibitory effects of Paeonia lactiflora root constituents and related compounds on antibiotic-susceptible and -resistant strains of Helicobacter pylori.

  Journal of agricultural and food chemistry 20120912

• Characterization of cobalt(III) hydroxamic acid complexes based on a tris(2-pyridylmethyl)amine scaffold: reactivity toward cysteine methyl ester.

  Inorganic chemistry 20120903

• Amelioration of metal-induced toxicity in Caenorhabditis elegans: utility of chelating agents in the bioremediation of metals.

  Toxicological sciences : an official journal of the Society of Toxicology 20120901

• Synthesis, biological evaluation, and molecular docking studies of 2,5-substituted-1,4-benzoquinone as novel urease inhibitors.

  Bioorganic & medicinal chemistry 20120815

• Simple pseudo-dipeptides with a P2' glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins.

  The Journal of biological chemistry 20120803

• Synthesis, inhibitory activity and molecular docking studies of two Cu(II) complexes against Helicobacter pylori urease.

  Journal of enzyme inhibition and medicinal chemistry 20120801

• Studies of histidine residues in soybean (Glycine max) urease.

  Protein and peptide letters 20120601

• N-substituted aminomethanephosphonic and aminomethane-P-methylphosphinic acids as inhibitors of ureases.

  Amino acids 20120501

• The physiological implications of urease inhibitors on N metabolism during germination of Pisum sativum and Spinacea oleracea seeds.

  Journal of plant physiology 20120501

• Modulation of Wnt/β-catenin signaling and proliferation by a ferrous iron chelator with therapeutic efficacy in genetically engineered mouse models of cancer.

  Oncogene 20120112

• Enhanced Bioavailability and Dissolution of Atorvastatin Calcium from Floating Microcapsules using Minimum Additives.

  Scientia pharmaceutica 20120101

• Chitosan-alginate microcapsules of amoxicillin for gastric stability and mucoadhesion.

  Journal of advanced pharmaceutical technology & research 20120101

• Allosteric effects of sulfonate anions on the rates of iron release from serum transferrin.

  Journal of inorganic biochemistry 20110901

• Bis(acetohydroxamato-κO,O')diphenyl-tin(IV).

  Acta crystallographica. Section E, Structure reports online 20110801

• Novel lipophilic acetohydroxamic acid derivatives based on conformationally constrained spiro carbocyclic 2,6-diketopiperazine scaffolds with potent trypanocidal activity.

  Journal of medicinal chemistry 20110728

• Urease inhibitors as potential drugs for gastric and urinary tract infections: a patent review.

  Expert opinion on therapeutic patents 20110601

• An improved bioprocess for synthesis of acetohydroxamic acid using DTT (dithiothreitol) treated resting cells of Bacillus sp. APB-6.

  Bioresource technology 20110601

• One-electron oxidation of acetohydroxamic acid: the intermediacy of nitroxyl and peroxynitrite.

  The journal of physical chemistry. A 20110414

• Identifying chelators for metalloprotein inhibitors using a fragment-based approach.

  Journal of medicinal chemistry 20110127

• Structural and functional role of nickel ions in urease by molecular dynamics simulation.

  Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20110101

• Amoxicillin loaded chitosan-alginate polyelectrolyte complex nanoparticles as mucopenetrating delivery system for h. Pylori.

  Scientia pharmaceutica 20110101

• The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors.

  European journal of medicinal chemistry 20101101

• Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

  Bioorganic & medicinal chemistry letters 20101101

• Synthesis, molecular docking and biological evaluation of Schiff base transition metal complexes as potential urease inhibitors.

  European journal of medicinal chemistry 20101001

• Computer-aided optimization of phosphinic inhibitors of bacterial ureases.

  Journal of medicinal chemistry 20100812

• Synthesis, structures, and urease inhibitory activities of three copper(II) and zinc(II) complexes with 2-{[2-(2-hydroxyethylamino)ethylimino]methyl}-4-nitrophenol.

  European journal of medicinal chemistry 20100701

• Entropic contribution to the linking coefficient in fragment based drug design: a case study.

  Journal of medicinal chemistry 20100527

• X-ray absorption spectroscopy of aqueous aluminum-organic complexes.

  The journal of physical chemistry. A 20100527

• Inhibitors of human histone deacetylase: synthesis and enzyme assay of hydroxamates with piperazine linker.

  Archiv der Pharmazie 20100301

• 13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis.

  PloS one 20100101

• Redox reactions of Pu(IV) and Pu(III) in the presence of acetohydroxamic acid in HNO(3) solutions.

  Inorganic chemistry 20091221

• The interaction of zinc(II) and hydroxamic acids and a metal-triggered Lossen rearrangement.

  Chemistry (Weinheim an der Bergstrasse, Germany) 20091214

• Lipoamide dehydrogenase and diaphorase catalyzed conversion of some NO donors to NO and reduction of NO scavenger 2-phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide (PTIO).

  General physiology and biophysics 20091201

• Inhibitors of bacterial N-succinyl-L,L-diaminopimelic acid desuccinylase (DapE) and demonstration of in vitro antimicrobial activity.

  Bioorganic & medicinal chemistry letters 20091115

• Medical treatment of pediatric urolithiasis.

  Pediatric nephrology (Berlin, Germany) 20091101

• Synthesis, molecular docking and biological evaluation of metronidazole derivatives as potent Helicobacter pylori urease inhibitors.

  Bioorganic & medicinal chemistry 20091101

• Hydroxamic acids as a novel family of serine racemase inhibitors: mechanistic analysis reveals different modes of interaction with the pyridoxal-5'-phosphate cofactor.

  Journal of medicinal chemistry 20091008

• Amines and oximes derived from deoxybenzoins as Helicobacter pylori urease inhibitors.

  European journal of medicinal chemistry 20090501

• Adsorption of hydroxamate siderophores and EDTA on goethite in the presence of the surfactant sodium dodecyl sulfate.

  Geochemical transactions 20090101

• Heart protection by ischemic preconditioning: a novel pathway initiated by iron and mediated by ferritin.

  Journal of molecular and cellular cardiology 20081201

• Design, synthesis, and evaluation of novel organophosphorus inhibitors of bacterial ureases.

  Journal of medicinal chemistry 20080925

• Extended triple-bridged Ni(II)- and Co(II)-hydroxamate trinuclear complexes: synthesis, crystal structures, and magnetic properties.

  Inorganic chemistry 20080804

• Reduction of pertechnetate by acetohydroxamic acid: formation of [TcII(NO)(AHA)2(H2O)]+ and implications for the UREX process.

  Inorganic chemistry 20080804

• Chelated iron sources are inhibitors of Pseudomonas aeruginosa biofilms and distribute efficiently in an in vitro model of drug delivery to the human lung.

  Journal of applied microbiology 20080801

• Immobilised metal affinity chromatography for the capture of hydroxamate-containing siderophores and other Fe(III)-binding metabolites directly from bacterial culture supernatants.

  The Analyst 20080701

• Floating in situ gelling system of acetohydroxamic acid for clearance of H. pylori.

  Drug development and industrial pharmacy 20080601

• Enzymatic, immunological and phylogenetic characterization of Brucella suis urease.

  BMC microbiology 20080101

• Vasorelaxant activity of some oxime derivatives.

  European journal of pharmacology 20071201

• Preparation and in vitro characterization of gellan based floating beads of acetohydroxamic acid for eradication of H. pylori.

  Acta pharmaceutica (Zagreb, Croatia) 20071201

• Jack bean urease: the effect of active-site binding inhibitors on the reactivity of enzyme thiol groups.

  Bioorganic chemistry 20071001

• A membrane associated metalloprotease cleaves Cry3Aa Bacillus thuringiensis toxin reducing pore formation in Colorado potato beetle brush border membrane vesicles.

  Biochimica et biophysica acta 20070901

• Design of novel histone deacetylase inhibitors.

  Bioorganic & medicinal chemistry letters 20070815

• Benzo[b]thiophene-based histone deacetylase inhibitors.

  Bioorganic & medicinal chemistry letters 20070815

• Spectroscopic study of the uranyl-acetohydroxamate adduct with tributyl phosphate.

  Applied spectroscopy 20070701

• Polyphenols based on isoflavones as inhibitors of Helicobacter pylori urease.

  Bioorganic & medicinal chemistry 20070601

• Exploring the subtleties of drug-receptor interactions: the case of matrix metalloproteinases.

  Journal of the American Chemical Society 20070307

• Laccase induction in fungi and laccase/N-OH mediator systems applied in paper mill effluent.

  Bioresource technology 20070101

• Simultaneous Determination of Cobalt(II) and Nickel(II) by Fourth-Order Derivative Spectrophotometric Method Using 2-Hydroxy-3-Methoxy Benzaldehyde Thiosemicarbazone.

  Journal of automated methods & management in chemistry 20070101

• Interaction of imidazole containing hydroxamic acids with Fe(III): hydroxamate versus imidazole coordination of the ligands.

  Bioinorganic chemistry and applications 20070101

• Bioactive oligostilbenoids from the stem bark of Hopea exalata.

  Journal of natural products 20061201

• Infrared spectroscopic studies of siderophore-related hydroxamic acid ligands adsorbed on titanium dioxide.

  Langmuir : the ACS journal of surfaces and colloids 20061121

• Synthesis of bicyclic molecular scaffolds (BTAa): an investigation towards new selective MMP-12 inhibitors.

  Bioorganic & medicinal chemistry 20061115

• Near edge X-ray absorption fine structure spectroscopy of bacterial hydroxamate siderophores in aqueous solutions.

  The journal of physical chemistry. A 20061026

• Floating hot-melt extruded tablets for gastroretentive controlled drug release system.

  Journal of controlled release : official journal of the Controlled Release Society 20061010

• N-hydroxyurea--a versatile zinc binding function in the design of metalloenzyme inhibitors.

  Bioorganic & medicinal chemistry letters 20060815

• Di-, tri-, and tetranuclear zinc hydroxamate complexes as structural models for the inhibition of zinc hydrolases by hydroxamic acids.

  Inorganic chemistry 20060529

• Synthesis and antibacterial activity of novel oxazolidinones bearing N-hydroxyacetamidine substituent.

  Bioorganic & medicinal chemistry letters 20060501

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Towards third generation matrix metalloproteinase inhibitors for cancer therapy.

  British journal of cancer 20060410

• A new role for old ligands: discerning chelators for zinc metalloproteinases.

  Journal of the American Chemical Society 20060315

• Heterocyclic zinc-binding groups for use in next-generation matrix metalloproteinase inhibitors: potency, toxicity, and reactivity.

  Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20060301

• Alcohol and oxidative liver injury.

  Hepatology (Baltimore, Md.) 20060201

• Characterization and optimization of experimental variables within a reproducible bladder encrustation model and in vitro evaluation of the efficacy of urease inhibitors for the prevention of medical device-related encrustation.

  Journal of biomedical materials research. Part B, Applied biomaterials 20060101

• Pb(II)-binding capability of aminohydroxamic acids: primary hydroxamic acid derivatives of alpha-amino acids as possible sequestering agents for Pb(II).

  Journal of inorganic biochemistry 20060101

• Hard and soft X-ray absorption spectroscopic investigation of aqueous Fe(III)-hydroxamate siderophore complexes.

  The journal of physical chemistry. A 20051117

• Application of Fourier transform infrared spectroscopy for monitoring hydrolysis and synthesis reactions catalyzed by a recombinant amidase.

  Analytical biochemistry 20051101

• Chemistry of a Ni(II) acetohydroxamic acid complex: formation, reactivity with water, and attempted preparation of zinc and cobalt analogues.

  Inorganic chemistry 20051003

• DFT study of the V(IV)/V(V) oxidation mechanism in the presence of N-hydroxyacetamide.

  Journal of inorganic biochemistry 20050801

• Dimerization of the keto tautomer of acetohydroxamic acid-infrared matrix isolation and theoretical study.

  Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20050501

• Release of iron from ferritin by aceto- and benzohydroxamic acids.

  Inorganic chemistry 20050418

• Neutral acetohydroxamic acid coordination to a mononuclear Ni(II) center stabilized by an intramolecular hydrogen-bonding interaction.

  Chemical communications (Cambridge, England) 20050128

• Ternary ligand-zinc-hydroxamate complexes.

  Inorganic chemistry 20050110

• Urease-induced alkalinization of extracellular pH and its antitumor activity in human breast and lung cancers.

  Journal of experimental therapeutics & oncology 20050101

• Pyrazolylborate-zinc alkoxide complexes. 3. Acid-base reactions.

  Inorganic chemistry 20040920

• Receptor-mediated targeting of lipobeads bearing acetohydroxamic acid for eradication of Helicobacter pylori.

  Journal of controlled release : official journal of the Controlled Release Society 20040914

• Crystal structures of novel non-peptidic, non-zinc chelating inhibitors bound to MMP-12.

  Journal of molecular biology 20040820

• Mechanism of metal-mediated DNA damage induced by a metabolite of carcinogenic acetamide.

  Chemico-biological interactions 20040810

• Acetohydroxamate inhibition of the activity of urease from dehusked seeds of water melon (Citrullus vulgaris).

  Journal of enzyme inhibition and medicinal chemistry 20040801

• New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.

  Journal of the American Chemical Society 20040714

• Synthesis, antiprotozoal and cytotoxic activities of new N-(3,4-dimethyl-5-isoxazolyl)-1,2-naphthoquinone-4-amino derivatives.

  Farmaco (Societa chimica italiana : 1989) 20040601

• Soybean cultivars 'Williams 82' and 'Maple Arrow' produce both urea and ammonia during ureide degradation.

  Journal of experimental botany 20040401

• Jackbean, soybean and Bacillus pasteurii ureases: biological effects unrelated to ureolytic activity.

  European journal of biochemistry 20040401

• Relaxant effect of oxime derivatives in isolated rat aorta: role of nitric oxide (NO) formation in smooth muscle.

  Biochemical pharmacology 20040315

• Predominant role of basicity of leaving group in alpha-effect for nucleophilic ester cleavage.

  Bioorganic chemistry 20040201

• Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori.

  The Journal of pharmacy and pharmacology 20031201

• First row divalent transition metal complexes of aryl-appended tris((pyridyl)methyl)amine ligands: syntheses, structures, electrochemistry, and hydroxamate binding properties.

  Inorganic chemistry 20031117

• Deprotonation sites of acetohydroxamic acid isomers. A theoretical and experimental study.

  The Journal of organic chemistry 20030822

• Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori.

  Journal of drug targeting 20030801

• Kinetics and mechanism of iron(III)-nitrilotriacetate complex reactions with phosphate and acetohydroxamic acid.

  Inorganic chemistry 20030630

• Potentiometric, spectrophotometric and density functional study of the interaction of N-hydroxyacetamide with oxovanadium(IV): the influence of ligand to the V(IV)/V(V) oxi-reduction reaction.

  Journal of inorganic biochemistry 20030501

• Catalysis of the beta-elimination of HF from isomeric 2-fluoroethylpyridines and 1-methyl-2-fluoroethylpyridinium salts. Proton-activating factors and methyl-activating factors as a mechanistic test to distinguish between concerted E2 and E1cb irreversible mechanisms.

  The Journal of organic chemistry 20030207

• A new approach in gastroretentive drug delivery system using cholestyramine.

  Drug delivery 20030101

• [Antimicrobial action of ammonium salts of fused heterocycles containing ortho-nitrogen].

  Medicina (Kaunas, Lithuania) 20030101

• NMR-based modification of matrix metalloproteinase inhibitors with improved bioavailability.

  Journal of medicinal chemistry 20021219

• Elucidating drug-metalloprotein interactions with tris(pyrazolyl)borate model complexes.

  Inorganic chemistry 20021007

• Design and synthesis of novel inhibitors of gelatinase B.

  Bioorganic & medicinal chemistry letters 20020819

• Dianionic complexes with hexacoordinate silicon(IV) or germanium(IV) and three bidentate ligands of the hydroximato(2-) type: syntheses and structural characterization in the solid state.

  Inorganic chemistry 20020729

• A novel general route for the preparation of enantiopure imidazolines.

  The Journal of organic chemistry 20020531

• Formation and structure of 1:1 complexes between aryl hydroxamic acids and vanadate at neutral pH.

  Inorganic chemistry 20020520

• Acetamidoquinone and acetamidohydroxy derivatives as inhibitors for both dihydroxyacetamido epoxidase and dehydrogenase.

  Bioorganic & medicinal chemistry 20020501

• Thermodynamics, kinetics, and mechanism of the stepwise dissociation and formation of Tris(L-lysinehydroxamato)iron(III) in aqueous acid.

  Inorganic chemistry 20020325

• Urease activity in microbiologically-induced calcite precipitation.

  Journal of biotechnology 20020214

• Purification and characterization of urease isolated from the pathogenic fungus Coccidioides immitis.

  Medical mycology 20020201

• Suppression of Helicobacter pylori-induced gastritis by urease inhibitors in Mongolian gerbils.

  Gan to kagaku ryoho. Cancer & chemotherapy 20020201

• Kinetics of inhibition and molecular asymmetry in pigeonpea (Cajanus cajan) urease.

  Journal of biochemistry, molecular biology, and biophysics : JBMBB : the official journal of the Federation of Asian and Oceanian Biochemists and Molecular Biologists (FAOBMB) 20020201

• Inhibition of bacteriophage lambda protein phosphatase by organic and oxoanion inhibitors.

  Biochemistry 20020122

• Floating-bioadhesive microspheres containing acetohydroxamic acid for clearance of Helicobacter pylori.

  Drug delivery 20020101

• Magnetic, spectroscopic, and structural studies of dicobalt hydroxamates and model hydrolases.

  Inorganic chemistry 20011105

• Marked reduction of Helicobacter pylori-induced gastritis by urease inhibitors, acetohydroxamic acid and flurofamide, in Mongolian gerbils.

  Biochemical and biophysical research communications 20010720

• Identification of novel potent hydroxamic acid inhibitors of peptidyl deformylase and the importance of the hydroxamic acid functionality on inhibition.

  Bioorganic & medicinal chemistry letters 20010604

• Supramolecular assembly and acid resistance of Helicobacter pylori urease.

  Nature structural biology 20010601

• Structure-based computational study of the catalytic and inhibition mechanisms of urease.

  Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry 20010301

• Interaction between iron(II) and hydroxamic acids: oxidation of iron(II) to iron(III) by desferrioxamine B under anaerobic conditions.

  Journal of inorganic biochemistry 20010115

• Synergistic binding of ligands to angiotensin-converting enzyme.

  The Journal of biological chemistry 19880325

• N-hydroxy-2-acetylaminofluorene as effective inhibitor of aldehyde oxidase.

  Biochemical and biophysical research communications 19860716

• Microsome- and hepatocyte-mediated mutagenicity of hydroxyurea and related aliphatic hydroxamic acids in V79 Chinese hamster cells.

  Mutation research 19850101

• Inhibition of urease by miscellaneous ions and compounds. Implications for the therapy of infection-induced urolithiasis.

  Investigative urology 19770901